Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03709758
Title Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naive AML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Venetoclax

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST